Abdominal Incision Injection of Liposomal Bupivacaine and Opioid Use after Laparotomy for Gynecologic Malignancies

Obstetrics and Gynecology

Volumn 128, Issue 5, 2016, Pages 1009-1017

  Kalogera, Eleftheria ^a   Bakkum Gamez, Jamie N ^a   Weaver, Amy L ^a   Moriarty, James P ^a   Borah, Bijan J ^a   Langstraat, Carrie L ^a   Jankowski, Christopher J ^a   Lovely, Jenna K ^a   Cliby, William A ^a   Dowdy, Sean C ^a,b  

^a MAYO CLINIC   (United States)

^b 200 1st Street SW ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN HYDROGEN TARTRATE PLUS BUPIVACAINE; ALVIMOPAN; BUPIVACAINE; MORPHINE; PLACEBO; TRAMADOL; LIPOSOME; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DRUG COST; DRUG USE; FEMALE; FEMALE GENITAL TRACT CANCER; HUMAN; HYSTERECTOMY; LAPAROTOMY; LENGTH OF STAY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; OMENTECTOMY; PAIN INTENSITY; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE ILEUS; POSTOPERATIVE NAUSEA; POSTOPERATIVE PAIN; POSTOPERATIVE VOMITING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; SKIN INCISION; CANCER STAGING; COMPARATIVE STUDY; ECONOMICS; GENITAL NEOPLASMS, FEMALE; INJECTION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PAIN; POSTOPERATIVE COMPLICATION; PROCEDURES; SURGICAL WOUND;

ADMINISTRATION, ORAL; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; BUPIVACAINE; COHORT STUDIES; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; INJECTIONS; LAPAROTOMY; LENGTH OF STAY; LIPOSOMES; MIDDLE AGED; MORPHINE; NEOPLASM STAGING; PAIN; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURGICAL WOUND;

EID: 84992317686     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001719     Document Type: Conference Paper

References (28)

1. Wells N, Pasero C, McCaffery M. Improving the quality of care through pain assessment and management. In: Hughes RG, editor. Patient safety and quality: an evidence-based handbook for nurses. Rockville (MD); Agency for Healthcare Research and Quality; 2008
2. American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on acute pain management. Anesthesiology 2004;100:1573-81
3. Chester JF, Stanford BJ, Gazet JC. Analgesic benefit of locally injected bupivacaine after hemorrhoidectomy. Dis Colon Rectum 1990;33:487-9
4. Moiniche S, Kehlet H, Dahl JB. A qualitative and quantitative systematic review of preemptive analgesia for postoperative pain relief: the role of timing of analgesia. Anesthesiology 2002;96:725-41
5. Golf M, Daniels SE, Onel E. A phase 3, randomized, placebocontrolled trial of DepoFoam bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Adv Ther 2011; 28:776-88
6. U.S. Food and Drug Administration. FDA label approved on 10/28/2011 (PDF) for EXPAREL. Silver Spring (MD): U.S. Food and Drug Administration. Available at: http://www. accessdata.fda.gov/drugsatfda-docs/label/2011/022496s000lbl.pdf. Retrieved September 18, 2016
7. Richard BM, Newton P, Ott LR, Haan D, Brubaker AN, Cole PI, et al. The Safety of EXPAREL (bupivacaine liposome injectable suspension) administered by peripheral nerve block in rabbits and dogs. J Drug Deliv 2012;2012:962101
8. Richard BM, Ott LR, Haan D, Brubaker AN, Cole PI, Nelson KG, et al. The safety and tolerability evaluation of DepoFoam bupivacaine (bupivacaine extended-release liposome injection) administered by incision wound infiltration in rabbits and dogs. Expert Opin Investig Drugs 2011;20:1327-41
9. Davidson EM, Barenholz Y, Cohen R, Haroutiunian S, Kagan L, Ginosar Y. High-dose bupivacaine remotely loaded into multivesicular liposomes demonstrates slow drug release without systemic toxic plasma concentrations after subcutaneous administration in humans. Anesth Analg 2010;110:1018-23
10. Cohen SM. Extended pain relief trial utilizing infiltration of Exparel(), a long-acting multivesicular liposome formulation of bupivacaine: a phase IV health economic trial in adult patients undergoing open colectomy. J Pain Res 2012;5:567-72
11. Smoot JD, Bergese SD, Onel E, Williams HT, Hedden W. The efficacy and safety of DepoFoam bupivacaine in patients undergoing bilateral, cosmetic, submuscular augmentation mammaplasty: a randomized, double-blind, active-control study. Aesthet Surg J 2012;32:69-76
12. Kalogera E, Bakkum-Gamez JN, Jankowski CJ, Trabuco E, Lovely JK, Dhanorker S, et al. Enhanced recovery in gynecologic surgery. Obstet Gynecol 2013;122:319-28
13. American Pain Society. Principles of analgesic use in the treatment of acute pain and cancer pain. 6th ed. Glenview (IL): American Pain Society; 2008
14. Strasberg SM, Linehan DC, Hawkins WG. The accordion severity grading system of surgical complications. Ann Surg 2009;250:177-86
15. Delaney CP, Weese JL, Hyman NH, Bauer J, Techner L, Gabriel K, et al. Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery. Dis Colon Rectum 2005;48: 1114-25
16. Wolff BG, Michelassi F, Gerkin TM, Techner L, Gabriel K, Du W, et al. Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus. Ann Surg 2004;240:728-34
17. Van Grevenhof P, Wagner J, Naessens J, Darby C, Killian J, Helgeson ER, et al. Development of a multi-year populationbased data warehouse of standardized medical costs: methods and results. AMIA Annu Symp Proc 1998;1091
18. Wagner JL, Alberts SR, Sloan JA, Cha S, Killian J, O'Connell MJ, et al. Incremental costs of enrolling cancer patients in clinical trials: a population-based study. J Natl Cancer Inst 1999;91:847-53
19. Suri RM, Thompson JE, Burkhart HM, Huebner M, Borah BJ, Li Z, et al. Improving affordability through innovation in the surgical treatment of mitral valve disease. Mayo Clin Proc 2013;88:1075-84
20. Health Economics Resource Center. How do I adjust for the effects of inflation? Washington, DC: Department of Veterans Affairs, Veterans Health Administration; 2013
21. Agency for Healthcare Research and Quality. Using appropriate price indices for analyses of health care expenditures or income across multiple years (MEPS: Medical Expenditure Panel Survey). Rockville (MD): Agency for Healthcare Research and Quality; 2014
22. Centers for Medicare and Medicaid Services. Berenson-eggers type of service (BETOS). Available at: http://www.cms.gov/ Medicare/Coding/HCPCSReleaseCodeSets/BETOS.html. Retrieved April 29, 2015
23. Hollander M, Wolfe DA. Nonparametric statistical methods. New York (NY): John Wiley &Sons; 1973. p.75-82
24. Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ 2005;24:465-88
25. Gasanova I, Alexander J, Ogunnaike B, Hamid C, Rogers D, Minhajuddin A, et al. Transversus abdominis plane block versus surgical site infiltration for pain management after open total abdominal hysterectomy. Anesth Analg 2015;121:1383-8
26. Haas E, Onel E, Miller H, Ragupathi M, White PF. A doubleblind, randomized, active-controlled study for posthemorrhoidectomy pain management with liposome bupivacaine, a novel local analgesic formulation. Am Surg 2012;78:574-81
27. Bergese SD, Onel E, Morren M, Morganroth J. Bupivacaine extended-release liposome injection exhibits a favorable cardiac safety profile. Reg Anesth Pain Med 2012;37:145-51
28. Naseem A, Harada T, Wang D, Arezina R, Lorch U, Onel E, et al. Bupivacaine extended release liposome injection does not prolong QTc interval in a thorough QT/QTc study in healthy volunteers. J Clin Pharmacol 2012;52:1441-7